Robert A. Ashley
Direttore/Membro del Consiglio presso Rowpar Pharmaceuticals, Inc.
Profilo
Robert A.
Ashley is currently the Director at Rowpar Pharmaceuticals, Inc. He previously held positions such as Chairman, President & CEO at AmpliMed Corp., Director-Strategic Product Planning at Bristol Myers Squibb Co., Director at IMCOR Pharmaceutical Co., Senior Vice President-Commercial Development at CollaGenex Pharmaceuticals, Inc., Manager-National Sales at GE Healthcare Ltd.
(United Kingdom), Chief Scientific Officer & Executive VP at Vital Therapies, Inc., and Chief Technical Officer & Executive VP at Immunic, Inc. Ashley is a graduate of the University of Oxford.
Posizioni attive di Robert A. Ashley
| Società | Posizione | Inizio |
|---|---|---|
Rowpar Pharmaceuticals, Inc.
 Rowpar Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Rowpar Pharmaceuticals, Inc. provides oral and dental health solutions. The firm manufactures and markets oral care products which include Closys brand toothpaste, oral rinse and oral spray. The company was founded by Perry Ratcliff in 1991 and is headquartered in Scottsdale, AZ. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Robert A. Ashley
| Società | Posizione | Fine |
|---|---|---|
Vital Therapies, Inc.
 Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Direttore Tecnico/Scientifico/R&S | 12/04/2019 |
| IMMUNIC, INC. | Direttore Tecnico/Scientifico/R&S | 01/04/2019 |
AmpliMed Corp.
 AmpliMed Corp. Pharmaceuticals: MajorHealth Technology AmpliMed Corp. develops and manufactures drugs to treat cancer. Its products include amplimexon, amplizone and benzimidazole series. The firm is focused on the development of small-molecule oncology drugs with novel mechanisms of action. The company was founded by Evan M. Hersh, David S. Alberts, Robert Thomas Dorr and William A. Remers in 1989 and is headquartered in Tucson, AZ. | Amministratore Delegato | 01/03/2007 |
CollaGenex Pharmaceuticals, Inc.
 CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Corporate Officer/Principal | 01/12/2003 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/09/1994 |
Formazione di Robert A. Ashley
| University of Oxford | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| IMMUNIC, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Health Technology |
AmpliMed Corp.
AmpliMed Corp. Pharmaceuticals: MajorHealth Technology AmpliMed Corp. develops and manufactures drugs to treat cancer. Its products include amplimexon, amplizone and benzimidazole series. The firm is focused on the development of small-molecule oncology drugs with novel mechanisms of action. The company was founded by Evan M. Hersh, David S. Alberts, Robert Thomas Dorr and William A. Remers in 1989 and is headquartered in Tucson, AZ. | Health Technology |
IMCOR Pharmaceutical Co.
 IMCOR Pharmaceutical Co. Medical SpecialtiesHealth Technology IMCOR Pharmaceutical Co. is a development-stage pharmaceutical company focused on developing medical imaging pharmaceutical products. Currently, the company's core business focus has evolved from an operating entity conducting research and development, manufacturing and limited selling activities. The company was founded by H. Craig Dees and Eric A. Wachter on December 28, 1994 and is headquartered in San Diego, CA. | Health Technology |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Health Technology |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Health Technology |
Rowpar Pharmaceuticals, Inc.
Rowpar Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Rowpar Pharmaceuticals, Inc. provides oral and dental health solutions. The firm manufactures and markets oral care products which include Closys brand toothpaste, oral rinse and oral spray. The company was founded by Perry Ratcliff in 1991 and is headquartered in Scottsdale, AZ. | Health Technology |
- Borsa valori
- Insiders
- Robert A. Ashley
